Introduction
The periplasmic receptors of Escherichia coli are ideal proteins to manipulate in order to study the mode of binding of hydrophobic ligands of interest in the pharmaceutical industry and medical field. Especially interesting are the two periplasmic components of the branched-chain amino acid transport system in E.coli, namely the leucine-isoleucine-valine binding protein (LIV) and the leucine-specific binding protein (LS). These water-soluble receptors localize in the periplasmic space translocate small molecules to cytoplasm of the bacteria. The method of transport relies on the recognition of the binding protein to the membrane-bound components. A change of tertiary structure from the open to closed form is vitally important for this interaction (Luck and Falke, 1991a; Shilton et al., 1996) . The mechanism of cleft closure is a theme throughout nature. Thus, LIV has been used as a model for numerous studies of fastidious human proteins such as the N-terminal domain of the group I metabotropic glutamate receptors and the N-methyl-D-aspartate receptor (Bessis et al., 2000; Paoletti et al., 2000; Lynch and Guttmann, 2001) .
LIV and LS are~80% identical in amino acid content and have virtually the same three-dimensional structure in the unliganded form (Sack et al., 1989b) . However, the two periplasmic receptors have different specificities for ligands and the range of ligands for LS is much wider than originally observed in the initial studies of the proteins (Landick and Oxender, 1985; Adams et al., 1991) . LS binds leucine and phenylalanine and also the fluorinated analogs of both of these amino acids (Rahmanian et al., 1973; Adams et al., 1991; Luck and Johnson, 2000) . LIV recognizes leucine, isoleucine and valine and, to a lesser extent, threonine, serine and alanine, but to date LIV has not been shown to bind any fluorinated analogs of the amino acids. LS has been studied by X-ray crystallography but only in the open form without ligand. LIV has also been examined as an unliganded protein along with a liganded 'open' form where leucine is associated only with the N-terminal lobe of protein (Sack et al., 1989a) . No closed structure has been published and the mechanism of ligand binding is unknown.
These periplasmic receptors offer a unique opportunity to explore subtle differences in substrate specificity in the ligandbinding pocket. In addition, we have a unique prospect to explore the engineering of a specific binding pocket to accommodate a ligand of interest. Since LS binds fluorinated substrates, we may be able to expand the range of binding in the cleft to include fluorinated substances such as those used in biological warfare. Thus, our periplasmic binding protein could be used as a basis for building biomolecular scavengers for these agents.
In this light, we are gathering biophysical information concerning these proteins. One of our methods for studying the dynamics of these important proteins is 19 F NMR. 19 F NMR is a proven technique in the study of protein structure and dynamics because the fluorine nucleus is readily incorporated at specific sites within proteins where it provides a sensitive probe for low-resolution structural information (Luck and Falke, 1991a,b) . For proteins too large or unstable for full NMR structural determination, 19 F NMR gives valuable information about conformational changes since the nucleus is able to detect changes in the local conformational environment, including van der Waals packing interactions and local electrostatic fields. The biosynthetic incorporation of fluorine into tryptophan residues in receptor proteins has shown that the fluorine has little effect on the structure and function of protein (Danielson and Falke, 1996) . Each of the four Trp residues in LS is found in an interesting region of the structure (Figure 1 ): one in the binding cleft which may interact directly with the ligand, one near the hinge connecting the two domains, one buried in the N-terminal domain and a single Trp located on the C-domain. With these probes it is possible to examine both binding events within the cleft and global conformational change in this protein. In this work, we produced site-directed mutants of all four Trp residues. We labeled LS wild-type and four Trp to Phe mutants with 5-fluorotryptophan (5F-Trp) and assigned 19 F NMR resonances to specific Trp residues, which allowed us to study the dynamics and substrate binding.
Materials and methods

Preparation of mutants
Plasmid pKSty containing livK, the gene coding for the leucinespecific binding protein (LS) from E.coli, was obtained from the Oxender Laboratory, Michigan State (Oxender et al., 1980; Adams et al., 1991) . LS protein contains four Trp residues at the positions 18, 278, 320 and 336 (Figure 1) . In order to create mutants with Trp replaced by Phe in the primer sequence, a tryptophan codon TGG, at the positions mentioned above, was replaced by a phenylalanine codon TTC. Two primers for each mutant (Table I) were custom synthesized by Integrated DNA Technlogies (Coralville, IA). Site-directed mutagenesis was carried out with the Quick-Change mutagenesis kit (Stratagene, La Jolla, CA). Mutants W18F and W336F were screened by digestion with restriction enzyme TspRI, and mutants W278F and W320F were screened using DpnI and TaqI, respectively. Additionally, all mutants were confirmed by DNA sequencing using an Applied Biosystems 373S Model automated DNA sequencer at the Trudeau Institute (Saranac Lake, NY).
Protein production
Wild-type of plasmid pKSty and mutant plasmids were transformed in the BL21(DE3) strain of E.coli. Cells were grown at 37°C, to OD 600 ϭ 0.7 in LB medium supplemented with ampicillin (100 mg/ml). Cells were harvested, washed with 100 ml of M9 medium and resuspended in 1 l of M9 medium supplemented with 2 mM MgSO 4 , 0.1 mM CaCl 2 , 0.04% glucose, 1% casamino acids, 0.1% thiamine, 1% glycerol, 100 mg/ml ampicillin and 1 g 5F-Trp. The cultures were incubated to exhaust the residual Trp in the medium for 30 min, then isopropyl-β-D-thiogalactoside (IPTG) was added to a final concentration of 0.5 mM. Cells were pelleted after 4 h and proteins were isolated using a standard osmotic procedure. LS proteins, wild-type and mutants, were further purified by ion-exchange chromatography on a DEAE-Sephacel (Sack et al., 1989b) . The structure shows the four tryptophan residues that were labeled with 5-fluorotryptophan in the present study. Table I . Primers used for site-directed mutagenesis of LS proteins
856 column using a 0-0.25 M NaCl gradient in 10 mM Tris buffer, pH 7.5. The purified proteins were dialyzed in 10 mM potassium phosphate buffer, pH 6.9, supplemented with 0.02% NaN 3 . Proteins were screened by SDS-PAGE and visualized with Coomassie Brilliant Blue stain.
Linear combination of spectra
To determine the efficiency of 5F-Trp incorporation into the wild-type and mutant LS, we used a linear combination of UV spectral absorbance (LINCS) (Zemsky et al., 1999; Senear et al., 2002 
Fluorescence measurements
The experimental solutions for the binding determination and conformational stability experiments were prepared from concentrated stock solutions of 20 mM Tris, pH 7.1, and 10 M urea, each containing 0.5 µM of protein. For studies with ligands, proteins were incubated with a concentration of 50 mM to ensure that the proteins were saturated. The solutions were equilibrated for 12 h at room temperature at 25°C before recording the fluorescence spectra. All fluorescence measurements were carried out at ambient temperature using a Perkin-Elmer (Norwalk, CT) LS 50B luminescence spectrophotometer. The excitation and emission bandwidths were set to 5 nm. The samples were irradiated at 278 nm and the emission was monitored from 300 to 390 nm. The fluorescence intensity at 323 nm for all samples was plotted as a function of urea concentration to create an unfolding curve. We found the unfolding transitions by the Origin program from MicroCal (Northampton, MA). Non-linear regression fitting of a two-or three-state model was carried out using the same program.
Results and discussion
Protein production
Most laboratories have used auxotroph strains of E.coli to produce 5F-Trp-labeled proteins (Danielson and Falke, 1996) . We biosynthetically incorporated the fluorine label into LS proteins, wild-type and mutants, by expression of the livK gene in E.coli, BL21(DE3). The tryptophan auxotroph cell line W3110 did not produce high levels of LS. In addition, we observed protein degradation after induction with IPTG. We also observed lower efficiency of labeling in this auxotroph cell line.
The substitution of Phe for Trp in the mutant proteins did not affect protein expression or purification and the resulting yields were 50-80 mg of 5F-Trp-labeled protein per liter. Based on the LINCS examinations, 5F-Trp incorporation rates in LS and mutant proteins were between 90 and 100% (Table  II) . These results are much higher than those observed in other proteins expressed by a T7 promoter (Ross et al., 2000) .
The effect of fluorine labeling on the overall structural stability of LS and mutants was investigated by using intrinsic tryptophan fluorescence to monitor urea denaturation. The free energy of unfolding for both of the unlabeled and 5F-Trp labeled LS wild-type without ligand gave a ∆G°U H 2 O ϭ 38.0 Ϯ 4 kJ/mol (Skeels, 2001 ). The results indicate that fluorine incorporation does not disrupt the overall structural integrity of the protein.
F NMR assignments for the 5F-Trp residues in LS
The spectrum of wild-type 5F-Trp labeled LS with leucine in the binding pocket was compared with the individual spectra of the 5F-Trp-labeled single replacement mutants also with leucine in the binding pocket (Figure 2 ). Observing which peak in the wild-type spectrum was eliminated in the spectrum of each mutant led to unequivocal assignment of 5F-Trp 857 resonances in the 19 F NMR spectrum. In the wild-type spectrum all four 5F-Trp resonances can be clearly identified. There are two well-resolved peaks at -47.8 and -50.3 p.p.m. corresponding to 5F-Trp18 and 5F-Trp336, respectively. The resonances for 5F-Trp320 and 5F-Trp278 overlap slightly, indicating that they reside in a similar chemical environment. The small resonance at -49.6 p.p.m. in the wild-type spectrum represents a small fraction of unfolded or degraded protein, which is at the same frequency as observed for solvent-exposed 5F-Trp (Luck and Falk, 1991a) .
Effects of Trp to Phe mutations on 19 F NMR chemical shifts
The 19 F NMR spectra of the mutants are similar to that of the native 5F-Trp-labeled receptor except that a single resonance associated with the missing Trp is deleted. In addition to the deleted resonances, Trp substitution in the 278 position caused slight structural perturbations at position 18 in the binding pocket.
As shown in Figure 1 , the N-domain of LS contains Trp320, Trp278 and Trp18, which is also found in the binding cleft. The C-domain houses the single Trp336. In the 19 F NMR spectrum in Figure 2 we observe that the resonance corresponding to 5F-Trp336 is unaffected by the single replacement of the other Trp residues. In addition, the resonances of the 5F-Trp residues at positions 320 and 278 are not affected by the mutation of Trp336. There are, however, slight changes in the chemical shift of the resonance for 5F-Trp18 in mutant W278F compared with the corresponding resonance in the spectrum of the wild-type. This change in the chemical shift of 5F-Trp18 in mutant W278F without any other spectral differences from the wild-type suggests that the Trp to Phe mutations in fact perturb the protein structure in the area of the binding pocket. Without a closed form of the crystal structure with leucine bound, we can only surmise that this change in resonance position is due to shifts in secondary elements in the Nterminal domain. Trp278 is buried within the domain structure and shares structural components with the residues of the binding pocket. Reductions in ring size of tryptophan to phenylalanine may well affect the local interactions at Trp278, which may in turn perturb the local environment of Trp18 in the binding pocket through common elements. This similar perturbations of 5F-Trp resonances in Trp to Phe mutants are observed in the soluble tissue factor (Zemsky et al., 1999) and the glucose and galactose binding protein (Luck and Falke, 1991a) .
Structural effects of L-leucine binding
The above assignment enables the four 5F-Trp resonances to be used as probes of structural changes at four known positions within the native protein. The spectrum of the 5F-Trp wildtype protein after extensive dialysis in phosphate buffer is shown in Figure 3a . Even though the protein was subjected to NMR within 15 min of removal from dialysis, there is residual ligand present. There are eight broadened peaks for the four labeled Trps in the protein indicating multiple conformers in this sample. Figure 3b shows the same protein after excess L-leucine was added. The arrows in Figure 3a indicate the positions of the closed, liganded conformer and the lines drawn from Figure 3a to b show the structural effects observed at the 5F-Trp positions upon L-leucine binding.
The structural effects observed upon L-leucine binding to the mutants yield an analogous picture. From these data we were able to identify frequency shifts for each of the four labeled Trp residues. Figure 4 shows three mutants, LSW18F, the mutants, the missing resonances in the spectra of mutants with substoichiometric amounts of ligand allow one to assign the resonances in the spectrum of the extensively dialyzed sample of LS (Figure 3a ) and identify the chemical shifts of all of the 5F-Trps.
The resonance of 5F-Trp18 located in the binding pocket shows the largest frequency change upon binding with L-leucine. Trp18 lies directly in the open cleft of the binding pocket and is proposed to interact directly with ligand (Sack et al., 1989b) . This tryptophan is solvent exposed but, upon L-leucine binding, this residue would be buried within the cleft. The chemical shift of Trp18 in the unliganded state at -49.6 p.p.m. is the same as that of the free 5F-Trp in solvent (Luck and Falke, 1991b) . A chemical shift from -49.6 to -47.8 p.p.m. as observed when L-leucine is bound would indicate the Trp18 moved to very different chemical environment. This change in chemical shift implicates cleft closure and the direct structural interaction between the 5F-Trp18 and
Structural effects of L-phenylalanine on LS
The titration of L-phenylalanine into the partially empty 5F-Trp-labeled LS is shown in Figure 5 . With each addition of ligand the resonances in the 19 F NMR spectra sharpen and take on the appearance of the spectra of the L-leucine-bound receptor shown in Figure 2 , with the exception of the broad peak at -49.6 p.p.m. This resonance has the chemical shift of a solvent-exposed 5F-Trp and is fairly broad with saturating amounts of ligand present. One could surmise that the protein is exchanging between a closed form and an open form. Perhaps the L-phenylalanine is able to bind to the protein within the cleft but does not have the contacts to hold the protein in a closed form. The spectrum indicates a fluxional Curves were generated by a non-linear regression fitting of a three-state model (Eftink, 1995) carried out using Origin (Microcal, Northhampton, MA).
area within the protein near Trp18. Thus, we see the chemical shifts for three of the four Trps in the closed positions and Trp18 exchanging between two positions. These resonances are in slow exchange on the NMR time-scale. Addition of stochiometric amounts L-leucine to the sample with 1.025 mM L-phenylalanine produced a spectrum identical to that in Figure  3b , which confirms that L-leucine binds the 5F-Trp receptor more readily that L-phenylalanine. From studies in our laboratory we have shown from fluorescence data that L-phenylalanine binds to the unlabeled LS (Luck and Johnson, 2000) . Our data show K d s of 0.4 and 0.18 mM for L-leucine and L-phenylalanine, respectively. Urea denaturation studies of LS without and with ligands, L-leucine and L-phenylalanine, were performed. Figure 6 shows that it takes a higher amount of urea to denature the proteins when L-leucine and L-phenylalanine are bound in the substrate binding cleft. The unbound protein and L-phenylalanine-bound protein show a sigmoidal curve signifying a two-state denaturation process (Skeels, 2001) . However, the L-leucine-bound protein shown as triangles produces a three-state denaturation curve. These data further corroborate that L-phenylalanine binds to the protein but not in the same manner as L-leucine. We are investigating this further by X-ray crystallography and a future goal is to obtain a full structure by NMR.
To date we know that each of the Trp to Phe mutants binds leucine but the K d s have not been determined. Calorimetric studies to obtain binding data on both labeled and unlabeled LS and mutants are under way. Subsequent papers will report on the binding properties of the mutants. At present we have unequivocally assigned the resonances of the 19 F NMR spectrum of the wild-type LS and have shown that the mutants are indeed functional. We have shown that Trp to Phe mutations far from the binding pocket can affect the structure of the pocket and these must be taken into account when designing new proteins. We have shown by 19 F NMR that L-phenylalanine binds to the 5F-Trp receptor, but in a different manner to L-leucine. This has been further corroborated by urea denaturation studies on LS.
